Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
AssigneeNZL Corporation
InventorsLouis A. Luzzi, Thomas E. Needham, Zia Hossein, Polireddy Dondeti
Life of this patent
Estimating the term…
Loading patent…
AssigneeNZL Corporation
InventorsLouis A. Luzzi, Thomas E. Needham, Zia Hossein, Polireddy Dondeti
Estimating the term…
The present invention describes a surprising new and effective pharmaceutical composition comprising microparticles and a pharmaceutically acceptable carrier. In particular, the present invention describes a pharmaceutical composition containing microparticles off a matrix material into which is infused a therapeutic agent. The present invention further provides a method of infusing a therapeutic agent such as a protein or peptide into a matrix material to form microparticles containing said therapeutic agent by employing a compressed solvent which is normally gaseous at ambient temperature and pressure. A method is also disclosed of treating or preventing a disease in a mammal by administering to said mammal through a mucosal membrane an effective amount of a pharmaceutical composition comprising microparticles containing a therapeutic agent which effectively treats the disease or disorder.
A pharmaceutical composition comprising a matrix material selected from the group consisting of chitosan, algin, saturated polyglycolysed glyceride, glycerol palrnitostearate, saturated C12 to C22 fatty acid esters of polyalcohol, glyceryl and polyethylene glycol behenate, polyethylene oxide, and ammonium glycyrrhizinate in the form of microparticles containing a protein or peptide selected from the group consisting of insulin, glucagons, calcitonin, atrial naturetic peptide, muramyl dipeptides, secretin, cholecystokinin, thyrotrophin releasing hormone, thymopentin, adrenocorticotripic hormone, growth hormone releasing factor, enkephalin, oxytocin, vasopressin and luteinizing hormone releasing hormone said composition being produced by infusing into or onto said matrix material by:
A method of infusing a therapeutic agent selected from the group consisting of insulin, glucagons, calcitonin, atrial naturetic peptide, muramyl dipeptides, secretin, cholecystokinin, thyrotrophin releasing thymopentin, adrenocorticotripic hormone, growth hormone releasing factor, enkephalin, oxytocin, vasopressin and luteinizing hormone releasing hormone said composition being into a matrix material selected from the group consisting of chitosan, algin, saturated polyglycolysed glyceride, glycerol palmitostearate, saturated C12 to C22 fatty acid esters of polyalcohol, glyceryl and polyethylene glycol behenate, polyethylene oxide, and ammonium glycyrrhizinate wherein said method comprises:
A method of protecting and delivering a protein or peptide selected from the group consisting of insulin, glucagons, calcitonin, atrial naturetic peptide, muramyl dipeptides, secretin, cholecystokinin, thyrotrophin releasing hormone, thymopentin, adrenocorticotripic hormone, growth hormone releasing factor, enkephalin, oxytocin, vasopressin and luteinizing hormone releasing hormone said composition being to a mammal, said method comprising;
Dependencies are inferred from the claim text.